- Home
- ITT vs BMRN Comparison
ITT vs BMRN Comparison
Compare ITT & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITT
- BMRN
- Stock Information
- Founded
- ITT 1920
- BMRN 1996
- Country
- ITT United States
- BMRN United States
- Employees
- ITT N/A
- BMRN N/A
- Industry
- ITT Fluid Controls
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- ITT Industrials
- BMRN Health Care
- Exchange
- ITT Nasdaq
- BMRN Nasdaq
- Market Cap
- ITT 10.9B
- BMRN 12.1B
- IPO Year
- ITT N/A
- BMRN 1999
- Fundamental
- Price
- ITT $150.63
- BMRN $58.07
- Analyst Decision
- ITT Strong Buy
- BMRN Buy
- Analyst Count
- ITT 9
- BMRN 22
- Target Price
- ITT $165.50
- BMRN $93.43
- AVG Volume (30 Days)
- ITT 510.8K
- BMRN 2.2M
- Earning Date
- ITT 05-01-2025
- BMRN 05-01-2025
- Dividend Yield
- ITT 0.93%
- BMRN N/A
- EPS Growth
- ITT 22.94
- BMRN 152.82
- EPS
- ITT 6.28
- BMRN 2.71
- Revenue
- ITT $3,633,100,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- ITT $5.08
- BMRN $12.27
- Revenue Next Year
- ITT $4.53
- BMRN $10.08
- P/E Ratio
- ITT $23.96
- BMRN $21.47
- Revenue Growth
- ITT 6.99
- BMRN 19.36
- 52 Week Low
- ITT $105.64
- BMRN $52.93
- 52 Week High
- ITT $161.13
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- ITT 61.87
- BMRN 41.32
- Support Level
- ITT $145.41
- BMRN $57.27
- Resistance Level
- ITT $152.32
- BMRN $59.12
- Average True Range (ATR)
- ITT 2.61
- BMRN 1.40
- MACD
- ITT -0.41
- BMRN 0.06
- Stochastic Oscillator
- ITT 58.65
- BMRN 18.34
About ITT ITT Inc.
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.